219 related articles for article (PubMed ID: 30715514)
1. The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.
Le Rhun E; Devos P; Boulanger T; Smits M; Brandsma D; Rudà R; Furtner J; Hempel JM; Postma TJ; Roth P; Snijders TJ; Winkler F; Winklhofer S; Castellano A; Hattingen E; Capellades J; Gorlia T; Van den Bent M; Wen PY; Bendszus M; Weller M;
Neuro Oncol; 2019 May; 21(5):648-658. PubMed ID: 30715514
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal metastases: a RANO proposal for response criteria.
Chamberlain M; Junck L; Brandsma D; Soffietti R; Rudà R; Raizer J; Boogerd W; Taillibert S; Groves MD; Le Rhun E; Walker J; van den Bent M; Wen PY; Jaeckle KA
Neuro Oncol; 2017 Apr; 19(4):484-492. PubMed ID: 28039364
[TBL] [Abstract][Full Text] [Related]
3. Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort.
Le Rhun E; Devos P; Winklhofer S; Lmalem H; Brandsma D; Kumthekar P; Castellano A; Compter A; Dhermain F; Franceschi E; Forsyth P; Furtner J; Galldiks N; Gállego Pérez-Larraya J; Gempt J; Hattingen E; Hempel JM; Lukacova S; Minniti G; O'Brien B; Postma TJ; Roth P; Rudà R; Schaefer N; Schmidt NO; Snijders TJ; Thust S; van den Bent M; van der Hoorn A; Vogin G; Smits M; Tonn JC; Jaeckle KA; Preusser M; Glantz M; Wen PY; Bendszus M; Weller M
Neuro Oncol; 2022 Oct; 24(10):1726-1735. PubMed ID: 35157772
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR.
Seong M; Park S; Kim ST; Park SG; Kim YK; Kim HJ; Ahn MJ
J Neurooncol; 2020 Sep; 149(2):367-372. PubMed ID: 32897466
[TBL] [Abstract][Full Text] [Related]
5. Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients.
Griguolo G; Aldegheri V; Bottosso M; Pittaro A; Caumo F; Guarascio MC; Pouderoux S; Busato F; Miglietta F; Jacot W; Dieci MV; Darlix A; Guarneri V
Int J Cancer; 2023 Sep; 153(6):1217-1226. PubMed ID: 37243480
[TBL] [Abstract][Full Text] [Related]
6. Response Assessment in Neuro-Oncology Clinical Trials.
Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
[TBL] [Abstract][Full Text] [Related]
7. Identification and Characterization of Leptomeningeal Metastases Using SPINE, A Web-Based Collaborative Platform.
Deol M; Palotai M; Pinzon AM; Marciniak A; Bliault G; Covert E; Aizer A; Guenette JP; Desalvo MN; Li XT; Thomas A; Tran NA; Jacobson A; Huang R; Guttmann CRG
J Neuroimaging; 2021 Mar; 31(2):324-333. PubMed ID: 33332686
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis.
Freilich RJ; Krol G; DeAngelis LM
Ann Neurol; 1995 Jul; 38(1):51-7. PubMed ID: 7611725
[TBL] [Abstract][Full Text] [Related]
9. Postcontrast MRI of cranial meninges: leptomeningitis versus pachymeningitis.
Kioumehr F; Dadsetan MR; Feldman N; Mathison G; Moosavi H; Rooholamini SA; Verma RC
J Comput Assist Tomogr; 1995; 19(5):713-20. PubMed ID: 7560315
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.
Chamberlain M; Soffietti R; Raizer J; Rudà R; Brandsma D; Boogerd W; Taillibert S; Groves MD; Le Rhun E; Junck L; van den Bent M; Wen PY; Jaeckle KA
Neuro Oncol; 2014 Sep; 16(9):1176-85. PubMed ID: 24867803
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist].
Rudnicka H; Niwińska A; Gruszfeld A; Pieńkowski T
Neurol Neurochir Pol; 2003; 37(4):811-24. PubMed ID: 14746241
[TBL] [Abstract][Full Text] [Related]
12. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V
Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
[TBL] [Abstract][Full Text] [Related]
14. Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints.
Huang RY; Wen PY
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):705-718. PubMed ID: 27742111
[TBL] [Abstract][Full Text] [Related]
15. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
[TBL] [Abstract][Full Text] [Related]
16. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy.
Bokstein F; Lossos A; Siegal T
Cancer; 1998 May; 82(9):1756-63. PubMed ID: 9576299
[TBL] [Abstract][Full Text] [Related]
18. Imaging Criteria in Neuro-oncology.
Nowosielski M; Wen PY
Semin Neurol; 2018 Feb; 38(1):24-31. PubMed ID: 29548049
[TBL] [Abstract][Full Text] [Related]
19. Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Huang RY; Bi WL; Weller M; Kaley T; Blakeley J; Dunn I; Galanis E; Preusser M; McDermott M; Rogers L; Raizer J; Schiff D; Soffietti R; Tonn JC; Vogelbaum M; Weber D; Reardon DA; Wen PY
Neuro Oncol; 2019 Jan; 21(1):26-36. PubMed ID: 30137421
[TBL] [Abstract][Full Text] [Related]
20. Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.
Huang RY; Unadkat P; Bi WL; George E; Preusser M; McCracken JD; Keen JR; Read WL; Olson JJ; Seystahl K; Le Rhun E; Roelcke U; Koeppen S; Furtner J; Weller M; Raizer JJ; Schiff D; Wen PY
Neuro Oncol; 2019 Feb; 21(2):234-241. PubMed ID: 30085283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
